XML 32 R12.htm IDEA: XBRL DOCUMENT v3.23.1
Inventories
 3 Months Ended
Mar. 31, 2023
Inventory Disclosure [Abstract]  
Inventories Inventories
The Company purchases intravenous chemotherapy drugs and oral prescription drugs from various suppliers. See Note 2 for a summary of the Company’s policies relating to intravenous chemotherapy and oral prescription drugs inventory.
The Company’s inventories as of March 31, 2023 and December 31, 2022 were as follows:
(in thousands)March 31, 2023December 31, 2022
Oral drug inventory$2,185 $2,130 
IV drug inventory8,0697,131
Total$10,254 $9,261